InsidersTradesSigma
Follow the 경보제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 경보제약 has published 1 insider filings. Market capitalisation: €119.8bn. The latest transaction was reported on 5 March 2026 (Purchase). Among the most active insiders: 정희록. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
경보제약 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en la investigación y el desarrollo de medicamentos innovadores.